olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Generic: olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Labeler: endo usa, inc.Drug Facts
Product Profile
Brand Name
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Generic Name
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Labeler
endo usa, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
amlodipine besylate 10 mg/1, hydrochlorothiazide 12.5 mg/1, olmesartan medoxomil 40 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
49884-789
Product ID
49884-789_64db5fb3-c133-422f-9cf5-98e60d98bdc4
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206137
Listing Expiration
2026-12-31
Marketing Start
2016-10-26
Pharmacologic Class
Established (EPC)
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
49884789
Hyphenated Format
49884-789
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide (source: ndc)
Generic Name
olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide (source: ndc)
Application Number
ANDA206137 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/1
- 12.5 mg/1
- 40 mg/1
Packaging
- 90 TABLET, FILM COATED in 1 BOTTLE (49884-789-09)
- 30 TABLET, FILM COATED in 1 BOTTLE (49884-789-11)
Packages (2)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "64db5fb3-c133-422f-9cf5-98e60d98bdc4", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0349884787097", "0349884788094", "0349884786090", "0349884789091", "0349884790097"], "unii": ["0J48LPH2TH", "864V2Q084H", "6M97XTV3HD"], "rxcui": ["999967", "999986", "999991", "999996", "1000001"], "spl_set_id": ["268d12e8-1cfc-4086-b613-8fd94f2d7c4e"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Endo USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (49884-789-09)", "package_ndc": "49884-789-09", "marketing_start_date": "20161026"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (49884-789-11)", "package_ndc": "49884-789-11", "marketing_start_date": "20161026"}], "brand_name": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "product_id": "49884-789_64db5fb3-c133-422f-9cf5-98e60d98bdc4", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "49884-789", "generic_name": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "labeler_name": "Endo USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA206137", "marketing_category": "ANDA", "marketing_start_date": "20161026", "listing_expiration_date": "20261231"}